The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, E.
Right arrow Articles by Singer, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, E.
Right arrow Articles by Singer, S. M.
The Journal of Immunology, 2006, 176: 516-521.
Copyright © 2006 by The American Association of Immunologists

Neuronal Nitric Oxide Synthase Is Necessary for Elimination of Giardia lamblia Infections in Mice1

Erqiu Li, Ping Zhou and Steven M. Singer2

Department of Biology, Georgetown University, Washington, D.C. 20057

NO produced by inducible NO synthase (NOS2) is important for the control of numerous infections. In vitro, NO inhibits replication and differentiation of the intestinal protozoan parasite Giardia lamblia. However, the role of NO against this parasite has not been tested in vivo. IL-6-deficient mice fail to control Giardia infections, and these mice have reduced levels of NOS2 mRNA in the small intestine after infection compared with wild-type mice. However, NOS2 gene-targeted mice and wild-type mice treated with the NOS2 inhibitor N-iminoethyl-L-lysine eliminated parasites as well as control mice. In contrast, neuronal NOS (NOS1)-deficient mice and wild-type mice treated with the nonspecific NOS inhibitor NG-nitro-L-arginine methyl ester and the NOS1-specific inhibitor 7-nitroindazole all had delayed parasite clearance. Finally, Giardia infection increased gastrointestinal motility in wild-type mice, but not in SCID mice. Furthermore, treatment of wild-type mice with NG-nitro-L-arginine methyl ester or loperamide prevented both the increased motility and the elimination of parasites. Together, these data show that NOS1, but not NOS2, is necessary for clearance of Giardia infection. They also suggest that increased gastrointestinal motility contributes to elimination of the parasite and may also contribute to parasite-induced diarrhea. Importantly, this is the first example of NOS1 being involved in the elimination of an infection.




This article has been cited by other articles:


Home page
Am J Trop Med HygHome page
L. Ny, H. Li, S. Mukherjee, K. Persson, B. Holmqvist, D. Zhao, V. Shtutin, H. Huang, L. M. Weiss, F. S. Machado, et al.
A Magnetic Resonance Imaging Study of Intestinal Dilation in Trypanosoma cruzi-infected Mice Deficient in Nitric Oxide Synthase
Am J Trop Med Hyg, November 1, 2008; 79(5): 760 - 767.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Di Matteo, F. M. Scandurra, F. Testa, E. Forte, P. Sarti, M. Brunori, and A. Giuffre
The O2-scavenging Flavodiiron Protein in the Human Parasite Giardia intestinalis
J. Biol. Chem., February 15, 2008; 283(7): 4061 - 4068.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. G. Morrison, A. G. McArthur, F. D. Gillin, S. B. Aley, R. D. Adam, G. J. Olsen, A. A. Best, W. Z. Cande, F. Chen, M. J. Cipriano, et al.
Genomic Minimalism in the Early Diverging Intestinal Parasite Giardia lamblia
Science, September 28, 2007; 317(5846): 1921 - 1926.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
E. Li, A. Zhao, T. Shea-Donohue, and S. M. Singer
Mast Cell-Mediated Changes in Smooth Muscle Contractility during Mouse Giardiasis
Infect. Immun., September 1, 2007; 75(9): 4514 - 4518.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
Y. S. Andersen, F. D. Gillin, and L. Eckmann
Adaptive Immunity-Dependent Intestinal Hypermotility Contributes to Host Defense against Giardia spp.
Infect. Immun., April 1, 2006; 74(4): 2473 - 2476.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.